Overview
Chronic kidney disease (CKD) is one of the major adult complications of Alström Syndrome and, alongside heart failure, contributes significantly to the prognosis of the condition. Kidney involvement typically develops gradually, often becoming clinically apparent in adolescence or adulthood. Early detection and proactive management can substantially slow progression. This article covers what happens to the kidneys in Alström, how it's monitored, and what helps preserve kidney function.
How kidney disease develops in Alström
The kidneys in Alström are affected by:
- Direct ALMS1-related dysfunction in renal tubular cells (cilia in tubules play roles in flow sensing and tubular function)
- Severe insulin resistance and diabetes, which damage kidneys independently
- Hypertension, common in adult Alström
- Glomerulonephritis-like changes in some cases
- Hyperfiltration injury from systemic metabolic factors¹
The pattern is often described as slowly progressive nephropathy with progressive glomerulofibrosis.
Typical course
- Early childhood: kidneys typically appear normal
- Mid-childhood to adolescence: subtle abnormalities may emerge — mild proteinuria, microalbuminuria
- Late adolescence and adulthood: progressive decline in glomerular filtration rate (GFR) becomes evident in many patients
- Adulthood: end-stage renal disease (ESRD) develops in some patients, occasionally as early as the late teens²
Individual variation is significant. Some adults with Alström maintain reasonable kidney function into middle age; others reach end-stage disease earlier.
Symptoms
Early kidney disease is usually silent. Late-stage symptoms include:
- Fatigue
- Swelling of legs, hands, or face
- Reduced appetite
- Itching
- Difficulty concentrating
- Reduced urine output
- Anemia symptoms (fatigue, breathlessness)
Routine surveillance catches kidney changes before symptoms develop.
Monitoring
Recommended kidney surveillance:³
From childhood
- Annual serum creatinine with eGFR calculation
- Annual urinalysis including protein and blood
- Annual urine albumin-to-creatinine ratio
- Blood pressure measurement
As issues emerge
- More frequent monitoring of creatinine and urine markers
- Renal ultrasound to assess kidney structure
- Bloodwork for kidney-related effects: electrolytes, calcium, phosphate, PTH, vitamin D, hemoglobin
- Sometimes kidney biopsy if the cause of declining function isn't clear
In advanced disease
- More intensive monitoring
- Dialysis preparation when appropriate
- Transplant evaluation when appropriate
Slowing progression
Several measures help preserve kidney function:
Blood pressure control
Maintaining blood pressure in the recommended range (often <130/80 in CKD patients) protects kidneys. ACE inhibitors and ARBs are first-line both for blood pressure and for direct kidney protection.⁴
Diabetes control
Tight glucose control reduces kidney damage. HbA1c targets are individualized.
Avoiding kidney-toxic medications
- NSAIDs (ibuprofen, naproxen) — generally avoid in CKD
- Some antibiotics — dose adjusted for kidney function
- IV contrast for imaging — used carefully in CKD
SGLT2 inhibitors
SGLT2 inhibitors (empagliflozin, dapagliflozin) have proven benefits in slowing CKD progression in patients with diabetes. They've become increasingly important in management.⁵
Other measures
- Avoiding dehydration
- Adequate nutrition (consult a renal dietitian as kidney function declines)
- Treating anemia with iron and erythropoiesis-stimulating agents when needed
- Managing bone-mineral disorder of CKD
- Lifestyle measures (avoiding smoking, alcohol moderation)
Treatment of advanced disease
Dialysis
When kidneys can no longer maintain adequate function, dialysis options include:
- Hemodialysis — typically 3 times per week at a dialysis center
- Peritoneal dialysis — done at home, several times daily or overnight
- Both have specific considerations for someone with vision and other Alström features
Kidney transplant
For appropriate candidates, kidney transplant offers better outcomes than long-term dialysis. Considerations:
- Multi-organ involvement (cardiac, hepatic) affects candidacy
- Living donor or deceased donor options
- Immunosuppression interacts with diabetes and other Alström features
- Some patients have successfully received kidney transplants — sometimes in combination with heart transplant in selected cases⁶
We cover this in Kidney Transplant and Dialysis in Alström Syndrome.
Coordinating with the broader care team
Kidney disease management interacts with:
- Cardiology — kidney medications affect heart medications and vice versa
- Endocrinology — diabetes management drives kidney protection
- Hepatology — both kidney and liver impact medication metabolism
- Pulmonology — fluid balance is delicate when both organs are involved
- Surgery and anesthesia teams — perioperative kidney protection matters
Multidisciplinary Alström clinics help coordinate. Otherwise, families and patients often help bridge the team.
Common questions
Frequently asked questions
Short answers grounded in the article and the underlying references, so families can quickly understand the main point without losing the medical meaning.
Question
Will my child develop kidney disease?
Answer
Many adults with Alström develop some degree of kidney disease, with severity varying widely. Annual surveillance and proactive management protect function over time.
Question
How early can kidney disease appear?
Answer
End-stage renal disease has been described as early as mid-to-late teens in some patients with Alström. Most adults reach this stage later in life, if at all.
Question
Can kidney disease be reversed?
Answer
Once significant CKD has developed, it's typically not reversible — but progression can be slowed substantially with proactive management. Catching it early matters.
Question
Is dialysis worse than transplant?
Answer
Both are options. Transplant typically provides better outcomes and quality of life when feasible, but isn't appropriate for every patient. Many patients are on dialysis for years successfully.